GE HEALTHCARE TECHNOLOGIES INC.

NASDAQ: GEHC (GE HealthCare Technologies Inc.)

Last update: 22 hours ago

83.02

1.18 (1.44%)

Previous Close 81.84
Volume 2,395,569
Price / Earnings (Forward) 15.01
Price / Sales 1.74
Price / Book 3.22
52 Weeks Range
58.75 (-29%) — 89.77 (8%)
TTM Dividend Yield 0.18%
Profit Margin 11.03%
Operating Margin (TTM) 14.78%
Diluted EPS (TTM) 4.76
Quarterly Revenue Growth (YOY) 2.70%
Quarterly Earnings Growth (YOY) 50.80%
Total Debt/Equity (MRQ) 97.51%
Current Ratio (MRQ) 0.980
Operating Cash Flow (TTM) 1.78 B
Levered Free Cash Flow (TTM) 1.58 B
Return on Assets (TTM) 5.87%
Return on Equity (TTM) 26.44%

AIStockmoo Score

1.7
Value 30% 0.6
AI Insight info NA
Relative Valuation info NA
Financial Health info 0.6
Timing 30% 1.8
AI Technical info NA
Technical Oscillators info 4.0
Technical Moving Averages info -1.5
Candle Patterns info NA
Sentiment 20% 0.8
Analyst Consensus info 0.0
News Mood info 2.8
Smart Money 20% 3.2
Insider Activity info NA
Institutional Flow info 4.5
Short Interest info 0.1
Environment ×0.88
Macro Environment info -1.3
Sector vs Market (6M) -13.2%
Pillar Agreement ×1.25
Not in score
Price Volatility info -1.4
Final Score 1.67

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock GE HealthCare Technologies Inc. Mixed Bullish

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
GEHC - 0.18% - 3.22
DXCM - - - 11.97
PODD - - - 6.51
CBLL - - - 9.08
BWAY - - - 5.20
IRMD - 1.51% - 10.64

Select this tab to load the latest available analysis.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Sector Healthcare
Industry Medical Devices
Investment Style Mid Value
% Held by Insiders 0.28%
% Held by Institutions 80.26%

No data within this time range.

Institutions

Institutional ownership: 103.57%

Positions Holders Shares
Increased 584 45,810,983
Decreased 567 26,716,467
New 136 4,582,980
Sold out 119 4,142,872

SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.

Short Interest

Settlement Shares Days to cover
30 Oct 2026 18,256,312 4.9
15 Oct 2026 19,374,350 5.1
30 Sep 2026 18,520,401 4.7
15 Sep 2026 16,909,543 5.5
31 Aug 2026 18,955,374 7.5
14 Aug 2026 17,427,194 5.9

FINRA short interest via Nasdaq, reported twice a month.

Date Type Details
13 Nov 2026 Yahoo Finance GE HealthCare Forms MAGNUS Neuro Alliance to Advance MRI Research
GEHC's MAGNUS Neuro Alliance aims to advance neuroscience research, expand MRI applications and develop imaging biomarkers for neurological conditions.
12 Nov 2026 Yahoo Finance GE HealthCare Stock Outlook: Is Wall Street Bullish or Bearish?
Despite GE HealthCare’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
11 Nov 2026 Yahoo Finance GE HealthCare: 3 Key Takeaways for Long-Term Investors
Multiyear supply contracts and higher-margin product launches may help position the company to sustain margin expansion amid industry chip shortages.
10 Nov 2026 Yahoo Finance GEHC Expands Vscan Air AI Capabilities With Lung Guidance & AutoAS
GE HealthCare expands Vscan Air's AI capabilities with Lung Guidance and AutoAS, enhancing cardiopulmonary assessments and point-of-care diagnostic support.
10 Nov 2026 Yahoo Finance GE HealthCare announces intent to establish MAGNUS Neuro Alliance to unlock new possibilities in MRI for neuroscience
CHICAGO, November 10, 2026--GE HealthCare (Nasdaq: GEHC) today announced the intent to establish a collaborative research network focused on advancing neuroscience research leveraging an ultra high-gradient head-only 3.0T MR system1. The MAGNUS2 Neuro Alliance will bring together researchers and…
09 Nov 2026 Yahoo Finance GE HealthCare (GEHC) Raised Full-Year Guidance. Here’s What’s Behind Its Recovery.
We recently published Forget the High-Beta Hype: 10 ‘Sleep Well at Night’ Stocks to Buy Now, and GE HealthCare Technologies (NASDAQ:GEHC) came in 8th on the list. Yahoo Finance reported that the S&P 500 fell more than 4% on Thursday, November 5, its worst day since the April 2025 tariff crash…
07 Nov 2026 Yahoo Finance GE HealthCare Technologies (GEHC) Led A $160 Million Cardiac Imaging Investment
GE HealthCare Technologies (NasdaqGS:GEHC) led Laza Medical's Series B round, raising US$160 million to fund AI-based cardiac imaging. The financing aims to advance robotic imaging systems for cardiac procedures using artificial intelligence tools in clinical workflows. The partners plan broader…
05 Nov 2026 Yahoo Finance GE HealthCare Unveils Allia Celeo to Advance Interventional Imaging
GEHC's Allia Celeo launch expands its interventional imaging portfolio with AI-powered precision, flexible workflows and predictive service capabilities.
04 Nov 2026 Yahoo Finance Laza Medical Raises Up to $160 Million in Series B Financing Led by GE HealthCare to Advance Intelligent Imaging for Transforming the Cath Lab
Laza Medical, Inc., a Shifamed portfolio company pioneering AI-powered robotic imaging solutions for cardiac interventions, today announced it has raised up to $160 million in Series B structured financing. GE HealthCare led the round, with participation from returning investors Unorthodox…
04 Nov 2026 Yahoo Finance Tampa General Hospital Expands Advanced Image-Guided Care in Clinical Hybrid Operating Room Setting With GE HealthCare Allia Moveo
Tampa General Hospital (TGH) today announced the installation of GE HealthCare's Allia™ Moveo next-generation, image-guided therapy (IGT) solution into a clinical hybrid operating room at its hospital, part of the Tampa Medical & Research District (TMRD).
04 Nov 2026 Yahoo Finance GEHC Q3 Earnings Call Highlights Raised Outlook and Margin Risks
GE HealthCare raises its 2026 earnings outlook on strong Q3 results, but tariff risks, fourth-quarter growth concerns and margin pressures remain in focus.
Show more
TTM Dividend Yield 0.18%
3Y Average Dividend Yield 0.15%
Payout Ratio 2.63%
Expected Next Dividend Payment Feb 2027
Ex Date Announcement Date Payment Date Details
23 Oct 2026 22 Sep 2026 13 Nov 2026 0.04 Cash
24 Jul 2026 30 Jun 2026 14 Aug 2026 0.035 Cash
02 Apr 2026 12 Feb 2026 15 May 2026 0.035 Cash
09 Jan 2026 24 Nov 2025 13 Feb 2026 0.035 Cash
24 Oct 2025 24 Sep 2025 14 Nov 2025 0.035 Cash
25 Jul 2025 01 Jul 2025 15 Aug 2025 0.035 Cash
25 Apr 2025 27 Mar 2025 15 May 2025 0.035 Cash
14 Jan 2025 21 Nov 2024 14 Feb 2025 0.035 Cash
18 Oct 2024 18 Sep 2024 15 Nov 2024 0.03 Cash
19 Jul 2024 26 Jun 2024 15 Aug 2024 0.03 Cash
18 Apr 2024 22 Mar 2024 15 May 2024 0.03 Cash
12 Jan 2024 08 Dec 2023 15 Feb 2024 0.03 Cash
19 Oct 2023 22 Sep 2023 15 Nov 2023 0.03 Cash
20 Jul 2023 23 Jun 2023 15 Aug 2023 0.03 Cash
22 May 2023 25 Apr 2023 15 Jun 2023 0.03 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2026 0.145 4 0.18
2025 0.140 4 0.17
2024 0.120 4 0.15
2023 0.090 3 0.12

Recent Signals candle patterns and EMA crosses

▲ Golden cross 8 sessions ago · 03 Nov
Long term · EMA 50/200
The 50-day EMA crossed above the 200-day, a widely watched sign that the long-term trend has turned up.

AI Technical Analysis

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria